Insider Selling: Omada Health (NASDAQ:OMDA) CFO Sells $656,370.00 in Stock

Omada Health, Inc. (NASDAQ:OMDA) CFO Steven Cook sold 33,000 shares of the company’s stock in a transaction dated Friday, June 26th. The stock was sold at an average price of $19.89, for a total transaction of $656,370.00. Following the transaction, the chief financial officer owned 133,359 shares in the company, valued at approximately $2,652,510.51. This trade represents a 19.84% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Omada Health Trading Up 1.3%

OMDA traded up $0.28 during midday trading on Tuesday, hitting $21.95. The company had a trading volume of 853,685 shares, compared to its average volume of 1,070,637. Omada Health, Inc. has a twelve month low of $10.28 and a twelve month high of $26.92. The firm’s 50-day simple moving average is $16.83 and its 200-day simple moving average is $14.93.

Omada Health (NASDAQ:OMDA) last announced its earnings results on Thursday, May 7th. The company reported ($0.05) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.03. Omada Health had a negative net margin of 2.22% and a negative return on equity of 1.82%. The company had revenue of $78.05 million for the quarter. As a group, equities analysts anticipate that Omada Health, Inc. will post -0.01 earnings per share for the current fiscal year.

Institutional Trading of Omada Health

A number of institutional investors have recently bought and sold shares of the business. Geode Capital Management LLC acquired a new position in shares of Omada Health in the 2nd quarter valued at $637,000. Walleye Capital LLC acquired a new stake in shares of Omada Health during the second quarter worth $458,000. Ilex Capital Partners UK LLP bought a new stake in Omada Health in the second quarter valued at about $201,000. Soros Fund Management LLC bought a new stake in Omada Health in the second quarter valued at about $640,000. Finally, Raymond James Financial Inc. acquired a new position in Omada Health in the second quarter valued at about $32,000.

Analyst Upgrades and Downgrades

A number of brokerages have commented on OMDA. JPMorgan Chase & Co. decreased their price objective on Omada Health from $32.00 to $26.00 and set an “overweight” rating on the stock in a research report on Thursday, March 12th. Wells Fargo & Company boosted their target price on Omada Health from $17.00 to $18.00 and gave the stock an “equal weight” rating in a research report on Friday, May 8th. Citigroup reaffirmed an “outperform” rating on shares of Omada Health in a research note on Friday, May 8th. The Goldman Sachs Group reiterated a “buy” rating on shares of Omada Health in a report on Friday, May 8th. Finally, Wall Street Zen raised Omada Health from a “hold” rating to a “buy” rating in a report on Saturday. Ten analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Omada Health currently has an average rating of “Moderate Buy” and an average target price of $22.91.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.